Y. Sağdıç Karateke Et Al. , "Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio," 3th National İmmunotherapy and Oncology Congress , Antalya, Turkey, pp.42, 2019
Sağdıç Karateke, Y. Et Al. 2019. Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio. 3th National İmmunotherapy and Oncology Congress , (Antalya, Turkey), 42.
Sağdıç Karateke, Y., Demir, L., Yıldız, B., & Dincer, M., (2019). Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio . 3th National İmmunotherapy and Oncology Congress (pp.42). Antalya, Turkey
Sağdıç Karateke, Yasemin Et Al. "Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio," 3th National İmmunotherapy and Oncology Congress, Antalya, Turkey, 2019
Sağdıç Karateke, Yasemin S. Et Al. "Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio." 3th National İmmunotherapy and Oncology Congress , Antalya, Turkey, pp.42, 2019
Sağdıç Karateke, Y. Et Al. (2019) . "Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio." 3th National İmmunotherapy and Oncology Congress , Antalya, Turkey, p.42.
@conferencepaper{conferencepaper, author={Yasemin Sağdıç Karateke Et Al. }, title={Malignant Melanoma Clinicopathological Features and Prognostic Significance of Neutrophil Lymphocyte Ratio}, congress name={3th National İmmunotherapy and Oncology Congress}, city={Antalya}, country={Turkey}, year={2019}, pages={42} }